(Total Views: 381)
Posted On: 02/13/2021 1:51:58 PM
Post# of 145247
Thanks. If leronlimab can reduce HIV comorbidities such as neuropathy, central nervous system issues (HAND), general inflammation, etc. we'll see a significant increase in treatment market share -- which is potentially shorter term revenue.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)